期刊文献+

20500例恶性肿瘤患者贫血情况分析 被引量:4

Analysis of anemia in 20500 patients with malignant tumors
下载PDF
导出
摘要 目的分析20500例恶性肿瘤患者的贫血情况。方法回顾性分析2018年1~11月浙江省肿瘤医院收治的20500例恶性肿瘤患者临床资料,计算不同肿瘤相关性贫血(CRA)的发生率;分析不同CRA的严重程度;分析CRA的年龄分布和性别分布。结果20500例CRA发生率为23.7%,CRA发生率最高的为妇科肿瘤,其次为消化和泌尿系统肿瘤,头颈部肿瘤伴发贫血的发生率最低。CRA严重程度多数为1~2级[4424例(91.1%)],3~4级CRA 434例(8.9%)。CRA的患者年龄多分布在50~<70岁,占60.07%,30~<50岁次之,占20.87%,<30岁最少,占1.26%。男性的CRA发生率高于女性,差异有统计学意义(P<0.05)。结论CRA整体发生率较高,以1~2级贫血为主,男性CRA发生率高于女性。 Objective To analyze the anemia of 20500 patients with malignant tumor.Methods The clinical data of 20500 patients with malignant tumors admitted to Zhejiang cancer hospital from January to November 2018 were analyzed retrospectively,the incidence of different tumor associated anemia(CRA)was calculated.The severity of different CRA were analyzed.The age distribution and gender distribution of CRA were analyzed.Results The incidence of CRA in 20,500 cases was 23.7%.The highest incidence of CRA was gynecological tumors,followed by digestive and urinary system tumors.The incidence of head and neck tumors with anemia was the lowest.The severity of CRA was mostly 4,424(91.1%)in grades 1-2,and 434(8.9%)of CRA in grades 3-4.The age of CRA patients were mostly distributed from 50 to<70 years,accounting for 60.07%,followed by 30 to<50 years,accounting for 20.87%,and the youngest were less than 30 years,accounting for 1.26%.The incidence of CRA was higher in men than in women,the difference was statistically significant(P<0.05).Conclusion The overall incidence of CRA is high,with grade 1-2 anemia as the predominant factor,the incidence of CRA is higher in men than in women.
作者 裴王伟 姜慧芬 范润萍 陈勇毅 徐笑红 PEI Wang-wei;JIANG Hui-fen;FAN Run-ping;CHEN Yong-yi;XU Xiao-hong(Department of Clinical Laboratory,Zhejiang Cancer Hospital,Hangzhou 310022,China)
出处 《中国当代医药》 2020年第6期180-182,共3页 China Modern Medicine
基金 浙江省医药卫生科技计划项目(2019KY328)。
关键词 恶性肿瘤 贫血 肿瘤相关性贫血 血红蛋白 Malignant tumor Anemia Cancer related anemia Hemoglobin
  • 相关文献

参考文献2

二级参考文献12

  • 1陆再英,钟南山.全国高等学校教材内科学[M].北京:人民卫生出版社,2008:556.
  • 2Suthinee Ithimakin MD. Cancer Anemia Survey in Division of Medical Oneology at Siriarj Hospital(CAS)[J]. J Med Assoc Thai, 2009,92 (Suppl2) : S110.
  • 3M LV Jacober RL.Mamoni Anaemia in patients with cancer:roleof inflammatory activity oniron metabolism and severity of anae-mia12September 2006/Accepted:21 December 2006/Publishedonline:12June 2007.
  • 4Pronzato P.Cancer related anaem ia m anagem ent in the21st centu ry[J].Cancer Treat Rev,2006,32(Suppl 2):S1S3.
  • 5Nowrousian MR.Recombinant human eryt hropoietin in thetreatment of cancer related or chemot herapy induced anaemiainpatients with solid tumours[J].Med Oncol,1998,15(Suppl 1):S192.
  • 6林雪怡 陈志哲.恶性肿瘤与贫血.福建医药杂志,1984,1:049-049.
  • 7Verbeke N,Beguin Y.High prevalence of anaemia and limited useof therapy in cancer patients:a Belgian survey(Anaemia Day2008)[J].Support Care Cancer,2012,20(1):23.
  • 8Fenner M H,Ganser A.Erythropoietin in cancer-related anemia[J].Curr Opi Oncol,2008,20(6):685.
  • 9Calabrich A,Katz A.Management of anemia in cancer patients[J].Future Oncol,2011,7(4),507.
  • 10Ludwig H,Fritz E,Leitgeb C,et al.Anemia in cancer patients.Semin Oncol,1998,25(supply):2-6.

共引文献16

同被引文献35

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部